NCT04817410View on ClinicalTrials.gov

ED Initiated Oral Naltrexone for AUD

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

November 2, 2023

Conditions
Alcohol Use Disorder
Interventions
DRUG

Emergency Department Initiated Oral Naltrexone

Emergency Department Initiated Oral Naltrexone

Trial Locations (1)

10003

Mount Sinai Beth Israel, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04817410 - ED Initiated Oral Naltrexone for AUD | Biotech Hunter | Biotech Hunter